Combination therapies for weight loss and maintenance
TW202631180APending Publication Date: 2026-08-01ZIHIPP LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-10-20
- Publication Date
- 2026-08-01
Smart Images
Figure TWG2TA001070935_001 
Figure TWG2TA001070935_002 
Figure TWG2TA001070935_003
Abstract
The present disclosure provides combinations for reducing weight and / or preventing weight gain in a subject (e.g., an obese subject) comprising an amylin analog and a GLP-1 receptor agonist. As described herein, the GLP-1 receptor agonist and amylin analog can be administered to a subject in the same pharmaceutical composition or in separate pharmaceutical compositions (e.g., via simultaneous or subsequent administration).
Need to check novelty before this filing date? Find Prior Art